Research Article
Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
Table 2
Biochemical indices measure at baseline, median (range), mg/dL.
| | Danshen group () | Placebo group () | values |
| Lipid profile | | | | LDL cholesterol | 118 (95–151) | 123 (94–154) | 0.875 | HDL cholesterol | 52 (43–64) | 54 (46–67) | 0.436 | Total cholesterol | 197 (178–239) | 191 (172–243) | 0.527 | Triglycerides | 117 (85–168) | 121 (84–171) | 0.329 | Apolipoprotein A | 93 (83–126) | 94 (85–128) | 0.811 | Apolipoprotein B | 71 (62–104) | 73 (65–99) | 0.743 | Apolipoprotein E | 6.9 (5.2–8.6) | 7.2 (5.3–8.5) | 0.632 | Lipoprotein (a) | 30 (20–45) | 33 (24–41) | 0.237 | Liver function | | | | Gamma-glutamyl transpeptidase (IU/dL) | 2.8 (2.1–5.3) | 3.0 (2.5–5.1) | 0.165 | Total bilirubin | 0.5 (0.3–0.6) | 0.6 (0.4–0.8) | 0.175 | Indirect bilirubin | 0.4 (0.3–0.6) | 0.5 (0.3–0.5) | 0.268 | Direct bilirubin | 0.4 (0.2–0.5) | 0.3 (0.2–0.4) | 0.377 | Renal function | | | | Uric acid | 5.1 (4.5–6.9) | 5.5 (4.1–6.4) | 0.264 | Risk factor of heart disease | | | | Homocysteine | 22 (19–40) | 23 (21–42) | 0.459 |
|
|